feed,title,long_url,short_url
gNews,Structure Therapeutics (GPCR): Examining Valuation After Recent Share Price Momentum - Yahoo Finance,https://news.google.com/rss/articles/CBMimAFBVV95cUxPY3hWVFNRQ0dDd0Y3Xzd5d1JBQ0VOXzhjMV9WM0pZZXBOUVFQRUlva1ctcDFpSUV6Q29FaUFXeU1CT3Z6dmNRdVFKUTdjZjYyMEFPRVYxa0dsWEZ6RjNpYjFObkliRDV0OUthUFpjQTc1ZmdNU3lUZWZ3OTB0N3dEaDZrUTVGX0tlRnV0RzIzaExNd2Rhc1pZVg?oc=5,
gNews,Assessing Credit Acceptance (CACC) Valuation Following a Year of Heavy Insider Selling - Yahoo Finance,https://news.google.com/rss/articles/CBMikgFBVV95cUxORlFXb2dxNGJfdWZwZVdFVWEzSnFWU1VVeEdxZ003X0lwV1U0cmZ0b1FpLUFpSXY3YmI1ZVRFVWIxc2lrREtSVF9aMmtDcFBHN3pQREtfbTF5dkZjSTd2TzQ1b0Q0bGdlUGhpOUdnbFBFbDE5ZVpvSmR3YlpaV09XNlVjcTkySnYxUVNURGlRbVF0dw?oc=5,
gNews,Is Belc's (TSE:9974) Higher Dividend a Sign of Strength in Its Capital Allocation Strategy? - Yahoo Finance,https://news.google.com/rss/articles/CBMigAFBVV95cUxQUVEtbHJQU2lRWXo4YlBNZW93V242eXVaSXFxMVcwMW9XTnE1cmEwSWVSOFhnUjgtYlBMcDNNN2hTQ2Z6VGV2Q0toR2ppMWdUUkxGY21qbnpRM0ozVUNTcHcwUUdXcjRzRThJM1djY3I1aF8zYVQ3dUJQNTZwek5IbQ?oc=5,
gNews,Why Analysts Are Rethinking Coherent After New AI Deals and Analyst Upgrades - Yahoo Finance,https://news.google.com/rss/articles/CBMiiAFBVV95cUxORmFTYlRRYWhGZG5uZTRKYWlVQnppR2w3ZjhocjdQQjVwQ3JqczNJd1dhc0hhR1N6S0xfWHh2UVdNcHNHa3J2dWQ4c0tuanBSMnhoY1IwQ3NsS21MVTN4TFUwQS13a0dhdDZ5WjZSYldLeUlTWU1MclVGWkJzUC1XWjI2MjVfVTBu?oc=5,
